Hydrofarm Holdings Group (HYFM) risk factors, FY2025 10-K

Hydrofarm Holdings Group's FY2025 10-K, filed Mar 27, 2026, lists 70 risk factors in 7 groups. Against the prior year's 68: 5 new, 3 dropped, 10 substantially reworded.

Risk factors listed
707 groups
New this year
5vs 68 last year
Dropped
3since the prior 10-K
Substantially reworded
10of those kept
Section length
24k wordsItem 1A

What the changes say

  • Hydrofarm faces severe liquidity constraints, a going concern warning, and a $2.8 million deferred interest payment default on its Term Loan.
  • The company breached Nasdaq minimum equity rules and recorded massive impairment charges of $232.2 million in 2025.

What changed since the prior 10-K

New

  • NewRisks Relating to Our Business

    We are not able to meet our current working capital needs and contractual obligations

    We face severe liquidity constraints, deferred a $2.8 million interest payment on our Term Loan in February 2026, and doubt our ability to continue as a going concern.

  • NewRisks Relating to Our Business

    new products and product innovations require substantial research, development and marketing expenditures. We may be unable to invest in new products and innovations, and may be unable to recoup any such investments if our new products or innovations do not achieve market acceptance

    Our fertilizers and nutrients require regulatory approvals, and failure to secure them could delay product launches or trigger recalls and penalties.

  • NewRisks Relating to the Cannabis Industry

    Furthermore, the Term Loan restricts our ability and the ability of the Subsidiary Obligors to sell our products directly to U.S. Cannabis Industry Participants

    Our Term Loan restricts selling directly to U.S. cannabis industry participants, and federal illegality under the CSA limits our growth.

  • NewRisks Relating to Our Capital Stock

    We are currently not in compliance with the continued listing standards of Nasdaq, and if we are unable to regain compliance, our common stock will be delisted from the exchange

    We face Nasdaq delisting because our stockholder's deficit was approximately $(63) million and our market value fell below $35 million.

  • NewRisks Relating to Our Capital Stock

    If our shares of common stock become subject to the penny stock rules, it would become more difficult to trade our shares

    If delisted from Nasdaq and our stock drops below $5.00, our shares will become subject to penny stock rules, hindering trading.

Dropped

  • DroppedRisks Relating to the Cannabis Industry

    any from the DEA or otherwise arising under federal law. We could be implicated in such enforcement or sanctions because of the purchase of our products by such Cannabis Industry Participants

  • DroppedRisks Relating to the Cannabis Industry

    Furthermore, the Credit Facilities restrict our ability and the ability of the Subsidiary Obligors to sell our products directly to U.S. cannabis growers

  • DroppedRisks Relating to Our Capital Stock

    We may not meet continued listing requirements, our common stock may be delisted from the Nasdaq Capital Market, which could affect the market price and liquidity for our common stock and reduce our ability to raise additional capital

Reworded

  • 90% rewrittenRisks Relating to Our Indebtedness

    Substantially all of our and our Subsidiary Obligors’ assets are pledged to secure obligations under the Term Loan

    Added that we defaulted by deferring a $2.8 million interest payment on the Term Loan on February 4, 2026.

    Was: Substantially all of our and our Subsidiary Obligors’ assets are pledged to secure obligations under the Credit Facilities

  • 89% rewrittenRisks Relating to Our Business

    We may not be able to obtain sufficient capital and may be forced to limit the scope of our operations

    Added explicit disclosure that recurring operating losses and negative cash flows raise substantial doubt about our ability to continue as a going concern.

    Was: If we need additional capital to fund our operations, we may not be able to obtain sufficient capital and may be forced to limit the scope of our operations

  • 55% rewrittenRisks Relating to Our Business

    Our restructuring activities may increase our expenses and cash expenditures, and may not have the intended effects

    Updated cross-references and removed mention of the industry recession in our restructuring description.

  • 53% rewrittenRisks Relating to Our Business

    We may not successfully develop new products, improve existing products, or maintain our effectiveness in reaching consumers through rapidly evolving communication vehicles

    Added a sentence fragment regarding the development and introduction of new products.

    Was: We may not successfully develop new products or improve existing products or maintain our effectiveness in reaching consumers through rapidly evolving communication vehicles

  • 40% rewrittenRisks Relating to the Cannabis Industry

    Certain of our products may be purchased for use in new and emerging industries and/or be subject to varying, inconsistent, and rapidly changing laws, regulations, administrative practices, enforcement approaches, judicial interpretations, future scientific research and public perception

    Clarified that end-user demand in emerging industries like cannabis may not achieve predictable market acceptance.

  • 39% rewrittenRisks Relating to Our Business

    Long-lived assets and inventories represent a significant portion of our total assets and we may be required to record additional impairments or write-downs in future periods

    Updated balance sheet figures for 2025, noting lower inventories of $33.3 million and $232.2 million in asset impairment charges.

    Was: Long-lived assets and inventories represent a significant portion of our total assets and we may be required to record impairments or write-downs in future periods

  • 33% rewrittenRisks Relating to Our Capital Stock

    If we are unable to retain key personnel, we may not be able to implement our business plan and our business may fail; our headcount reductions may cause undesirable consequences

    Updated workforce reduction timeline to include 2025 alongside 2024 headcount cuts.

  • 27% rewrittenRisks Relating to Our Business

    Unanticipated changes in our tax provisions, the adoption of new tax legislation or exposure to additional tax liabilities could affect our profitability and cash flows

    Added implemented tax proposals to the list of factors affecting our effective tax rate.

  • 26% rewrittenRisks Relating to Our Indebtedness

    The Term Loan has restrictions on our ability to sell our products directly to the cannabis industry

    Was: The Credit Facilities have restrictions on our ability to sell our products directly to the cannabis industry

  • 26% rewrittenRisks Relating to the Cannabis Industry

    Cannabis Industry Participants are subject to federal and state controlled substance laws and regulations. As a result, we are indirectly subject to a number of risks related to controlled substances

All 70 risk factors

Headings as the filing states them, in filing order.

Risks Relating to Our Business

  1. 01We are not able to meet our current working capital needs and contractual obligationsNew
  2. 02We may not be able to obtain sufficient capital and may be forced to limit the scope of our operations89% rewritten
  3. 03Our proprietary brand offerings expose us to various risks
  4. 04Our restructuring activities may increase our expenses and cash expenditures, and may not have the intended effects55% rewritten
  5. 05We may not successfully develop new products, improve existing products, or maintain our effectiveness in reaching consumers through rapidly evolving communication vehicles53% rewritten
  6. 06new products and product innovations require substantial research, development and marketing expenditures. We may be unable to invest in new products and innovations, and may be unable to recoup any such investments if our new products or innovations do not achieve market acceptanceNew
  7. 07Our competitors and potential competitors may develop products and technologies that are more effective or commercially attractive than our products
  8. 08Long-lived assets and inventories represent a significant portion of our total assets and we may be required to record additional impairments or write-downs in future periods39% rewritten
  9. 09If we fail to manage our inventory effectively, our results of operations, financial condition and liquidity may be materially and adversely affected
  10. 10Our inventory is vulnerable to damage or loss caused by accidents or natural disasters, and we face the risk of theft of our products from inventory or during shipment
  11. 11We are exposed to manufacturing risks that could adversely affect our business and results of operations
  12. 12Our peat bogs are susceptible to sudden changes in weather and the impacts of climate change
  13. 13A significant product defect or product recall could materially and adversely affect our brand image, causing a decline in our sales and profitability, and could reduce or deplete our financial resources
  14. 14Potential tariffs or a global trade war could increase the cost of our products, which could adversely impact the competitiveness of our products and our financial results
  15. 15Increased prices and inflation could negatively impact our margin performance and our financial results
  16. 16We occupy many of our facilities under long-term non-cancellable leases, and we may be unable to renew, sublease or terminate and exit our leases
  17. 17A disruption in the operations of our freight carriers, higher shipping costs or shipping delays could disrupt our supply chain and could negatively impact our margin performance and our financial results
  18. 18Our international operations make us susceptible to the costs and risks associated with operating internationally
  19. 19Government laws and regulations, including environmental laws and regulations, could result in material costs or otherwise adversely affect our financial condition and results of operations
  20. 20regulations result in increased product or administrative costs, we may not be in a position to increase selling prices, and therefore an increase in costs could have a material adverse effect on our business, financial condition and results of operations
  21. 21Failure to optimize our supply chain or disruption of our supply chain could have an adverse effect on our business, financial condition and results of operations
  22. 22Scrutiny and evolving expectations from customers, regulators, investors, and other stakeholders with respect to our environmental, social and governance practices may impose additional costs on us or expose us to new or additional risks
  23. 23Climate change may impact the availability of our facilities, we may incur substantial costs to comply with climate change legislation and related regulatory initiatives, and weather conditions could adversely impact financial results
  24. 24If we fail to maintain effective internal controls over financial reporting or fail to comply with other regulations, investors may lose confidence in the accuracy and completeness of our financial reporting, and the price of our common stock may be adversely affected
  25. 25Damage to our reputation could have an adverse effect on our business
  26. 26Our marketing activities may not be successful
  27. 27Our operations may be impaired if our information technology systems, or those of our third-party vendors, fail to perform adequately or if we or our third-party vendors are the subject of a data breach or cyber-attack
  28. 28The estimates and judgments we make, or the assumptions on which we rely, in preparing our consolidated financial statements could prove inaccurate
  29. 29Unanticipated changes in our tax provisions, the adoption of new tax legislation or exposure to additional tax liabilities could affect our profitability and cash flows27% rewritten
  30. 30We may be limited in our ability to utilize, or may not be able to utilize, net operating loss carryforwards to reduce our future tax liability
  31. 31Acquisitions, other strategic alliances and investments could result in operating difficulties, dilution, and other harmful consequences that may adversely impact our business and results of operations
  32. 32If product liability lawsuits are brought against us, we may incur substantial liabilities

Risks Relating to Our Indebtedness

  1. 33Substantially all of our and our Subsidiary Obligors’ assets are pledged to secure obligations under the Term Loan90% rewritten
  2. 34The Term Loan has restrictions on our ability to sell our products directly to the cannabis industry26% rewritten

Risks Relating to Third Parties

  1. 35Disruptions in the availability or increases in the prices of raw materials sourced by suppliers could adversely affect our results of operations
  2. 36If our suppliers that currently, or will in the future, sell directly to the retail market in which we conduct our current or future business, or if our customers that currently, or will in the future, manufacture and sell competitive products, our ability to sell certain products could be harmed
  3. 37Disruption in our global supply chain or vendor relationships may negatively impact our businesses
  4. 38A significant interruption in the operation of our or our suppliers’ facilities could impact our capacity to produce products and service our customers, which could adversely affect revenues and earnings
  5. 39If our suppliers are unable to source raw materials in sufficient quantities, on a timely basis, and at acceptable costs, our ability to sell our products may be harmed

Risks Relating to the Cannabis Industry

  1. 40We are subject to a number of risks, directly and indirectly through Cannabis Industry Participants, because cannabis is illegal under federal law
  2. 41Cannabis Industry Participants are subject to federal and state controlled substance laws and regulations. As a result, we are indirectly subject to a number of risks related to controlled substances26% rewritten
  3. 42Furthermore, the Term Loan restricts our ability and the ability of the Subsidiary Obligors to sell our products directly to U.S. Cannabis Industry ParticipantsNew
  4. 43Certain of our products may be purchased for use in new and emerging industries and/or be subject to varying, inconsistent, and rapidly changing laws, regulations, administrative practices, enforcement approaches, judicial interpretations, future scientific research and public perception40% rewritten
  5. 44which is uncertain, as well as the laws governing the growth, possession, and use of cannabis by adults for both adult and medical use
  6. 45Our indirect involvement in the cannabis industry could affect the public’s perception of us and be detrimental to our reputation
  7. 46Businesses involved in the cannabis industry, and investments in such businesses, are subject to a variety of laws and regulations related to money laundering, financial recordkeeping and proceeds of crimes

Risks Relating to Other Regulations

  1. 47Certain state and other regulations pertaining to the use of certain ingredients in grow media and plant nutrients could adversely impact us by restricting our ability to sell such products
  2. 48We are currently subject to, and may in the future become subject to additional, U.S., state and foreign laws and regulations imposing obligations on how we collect, store and process personal information. Our actual or perceived failure to comply with such obligations could harm our business
  3. 49Compliance with, or violation of, environmental, health and safety laws and regulations, including laws pertaining to the use of pesticides, could result in significant costs that adversely impact our reputation, businesses, financial position, results of operations and cash flows
  4. 50We are a "smaller reporting company" and, because we have opted to use the reduced reporting requirements available to us, certain investors may find investing in our securities less attractive

Risks Relating to Our Intellectual Property

  1. 51We may not be able to adequately obtain, maintain, protect or enforce our intellectual property and other proprietary rights that are material to our business
  2. 52Obtaining and maintaining our patent protection depends on compliance with various procedural, document submissions, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for noncompliance with these requirements
  3. 53From time to time, we may need to rely on licenses to proprietary technologies, which may be difficult or expensive to obtain or we may lose certain licenses which may be difficult to replace, harming our competitive position
  4. 54Third parties may initiate legal proceedings alleging that we are infringing their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on the success of our business
  5. 55Intellectual property disputes could cause us to spend substantial resources and distract our personnel from their normal responsibilities
  6. 56If our owned or in-licensed trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected

Risks Relating to Our Capital Stock

  1. 57We may incur indebtedness or issue capital stock that ranks senior or equally to our common stock as to liquidation preference and other rights and which may dilute our stockholders’ ownership interest
  2. 58Provisions in our corporate charter documents and under Delaware law could make an acquisition of our company, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management
  3. 59Various provisions of our lending agreements with JPMorgan, in addition to our Certificate of Incorporation, Bylaws and other corporate documents, could delay or prevent a change of control
  4. 60We are currently not in compliance with the continued listing standards of Nasdaq, and if we are unable to regain compliance, our common stock will be delisted from the exchangeNew
  5. 61The market price of our common stock could be negatively affected by future sales of our common stock
  6. 62The price of our common stock has been, and may continue to be, volatile and may fluctuate substantially, which could result in substantial losses for purchasers of our common stock
  7. 63If our shares of common stock become subject to the penny stock rules, it would become more difficult to trade our shares New
  8. 64Our Certificate of Incorporation provides that the doctrine of "corporate opportunity" will not apply with respect to any director or stockholder who is not employed by us or our affiliates
  9. 65If we are unable to retain key personnel, we may not be able to implement our business plan and our business may fail; our headcount reductions may cause undesirable consequences33% rewritten
  10. 66Litigation may adversely affect our business, financial condition and results of operations
  11. 67Our equity incentive plans may have a dilutive effect on your percentage ownership and may result in a dilution of your voting power and an increase in the number of shares of common stock eligible for future resale in the public market, which may negatively impact the trading price of our shares of common stock
  12. 68Our security holders may be diluted by future issuances of securities by us
  13. 69Failure to comply with the U.S. Foreign Corrupt Practices Act could subject us to penalties and other adverse consequences
  14. 70Delaware law contains anti-takeover provisions that could deter takeover attempts that could be beneficial to our stockholders

Other Hydrofarm Holdings Group 10-Ks

  • FY2024 10-K risk factors
    68 risks

    Hydrofarm faces significant exposure to federal cannabis illegality, supply chain disruptions, international tariffs, and restructuring execution risks.

    Filed Mar 05, 2025

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.